TABLE 1.
Parameter | Methamphetamine | Amphetamine |
---|---|---|
Physicochemical | ||
Molecular weight (g/mol) | 149.23a | 135.21a |
Compound type | Basea | Basea |
pKa | 10.21a | 10.01a |
LogP | 2.23a | 1.85a |
fu,p | 0.77b | 0.82b |
B/P | 1.04b | 1.04b |
MDCK cellular permeability (10−6 cm/s) | 29.1b | 26.9b |
Absorption | ||
ka (h−1) | 5c | 5c |
Fa | 1c | 1c |
Fg | 1c | 1c |
Distribution | ||
Kp,adipose | 3d | 2d |
Kp,bone | 3d | 2d |
Kp,brain | 9.67e | 9.67e |
Kp,gastrointestinal tract | 25.2e | 25.2e |
Kp,heart | 5.21e | 5.21e |
Kp,kidney | 14.5e | 14.5e |
Kp,liver | 25e | 25e |
Kp,lung | 6.94e | 6.94e |
Kp,muscle | 3d | 2d |
Kp,pancreas | 12.7e | 12.7e |
Kp,skin | 3d | 2d |
Kp,spleen | 11e | 11e |
Metabolism (l/h) | ||
CLtotal | 18.0f (i.v.) | 15.8g (p.o.) |
CLh | 9.91h | 7.41h |
CLintrinsic | 14.4h | 9.87h |
CLf | — | 3.29i |
Excretion (l/h) | ||
CLr | 8.09f | 7.14j |
CLsecretion | 48k (16 × 3) | 30k (10 × 3) |
B/P, blood-to-plasma ratio; CLf, formation clearance; CLh, hepatic clearance; CLintrinsic, metabolic intrinsic clearance; CLr, renal clearance; CLsecretion, renal active secretion clearance at proximal tubule (clearance value of each proximal subsegment S1, S2, and S3); CLtotal, total body clearance (intravenous administration for methamphetamine; oral administration for amphetamine); Fa, fraction absorbed; Fg, fraction passed the enterocyte; ka, absorption rate constant from gut lumen to blood.
Collected from www.drugbank.ca.
Measured from experiments.
Assumed as described in Materials and Methods.
Optimized as described in Materials and Methods.
Derived as described in Materials and Methods.
Derived based on Lane and Levy (1980), CDER (2001), Newton et al. (2005).
Optimized as described in Materials and Methods.